A private circle of Silicon Valley executives, venture capitalists, and high ranking Trump administration officials has spent the last year operating within a government run Slack channel to steer the future of American medicine. This clandestine digital workspace has served as a direct pipeline for titans like Google, Microsoft, OpenAI, and Apple to lobby federal health regulators away from the public eye. Through this unconventional channel, the administration is pushing a vision where artificial intelligence manages medical records and provides patient care, potentially allowing these tech firms to bill Medicare for their services just as traditional doctors do.
The lack of transparency surrounding these discussions has raised significant legal concerns. While the Food and Drug Administration held listening sessions with dozens of industry organizations regarding conversational AI, these meetings never appeared on public calendars or official regulatory notices. Instead, invitations were sent via the messaging app. Legal experts suggest that this arrangement functions essentially as a federal advisory panel, which by law should be conducted in public view rather than tucked away in a private chat room managed by agency insiders.
Government leadership has remained bullish on the integration of these technologies into what they call the Health Technology Ecosystem. Former Department of Government Efficiency leader Amy Gleason helped facilitate the group, while CMS Administrator Mehmet Oz described the effort as giving industry a chance to play in the sandbox of government supported healthcare. Even HHS Secretary Robert F. Kennedy Jr. has voiced strong support for the shift, suggesting that AI could eventually be more informed than any human physician in the country.
However, medical professionals are sounding alarms over the speed and secrecy of this transition. Dr. John Whyte of the American Medical Association warned that many of these tools are not yet ready for primetime and questioned who bears liability when an algorithm makes a clinical error. As federal officials promote a curated library of commercial apps to millions of seniors and people with disabilities, critics fear that patient privacy is being traded for corporate profit under a regime of loose regulation and closed door dealmaking.
